A detailed history of Geode Capital Management, LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,578,794 shares of CTKB stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,578,794
Previous 2,508,016 2.82%
Holding current value
$12.6 Million
Previous $16.8 Million 14.49%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$5.3 - $6.91 $375,123 - $489,075
70,778 Added 2.82%
2,578,794 $14.4 Million
Q1 2024

May 13, 2024

BUY
$6.29 - $9.15 $323,815 - $471,051
51,481 Added 2.1%
2,508,016 $16.8 Million
Q4 2023

Feb 13, 2024

BUY
$4.1 - $9.51 $418,540 - $970,809
102,083 Added 4.34%
2,456,535 $22.4 Million
Q3 2023

Nov 13, 2023

BUY
$5.52 - $9.5 $1.61 Million - $2.78 Million
292,150 Added 14.17%
2,354,452 $13 Million
Q2 2023

Aug 11, 2023

BUY
$6.69 - $11.99 $1.29 Million - $2.31 Million
192,832 Added 10.31%
2,062,302 $17.6 Million
Q1 2023

May 15, 2023

BUY
$8.44 - $13.47 $703,347 - $1.12 Million
83,335 Added 4.67%
1,869,470 $17.2 Million
Q4 2022

Feb 13, 2023

BUY
$9.71 - $15.86 $538,584 - $879,706
55,467 Added 3.2%
1,786,135 $18.2 Million
Q3 2022

Nov 14, 2022

BUY
$10.96 - $15.45 $6.41 Million - $9.04 Million
585,198 Added 51.09%
1,730,668 $25.5 Million
Q2 2022

Aug 12, 2022

BUY
$7.41 - $11.56 $1.66 Million - $2.59 Million
224,330 Added 24.35%
1,145,470 $12.3 Million
Q1 2022

May 13, 2022

BUY
$9.89 - $17.25 $5.6 Million - $9.76 Million
566,000 Added 159.37%
921,140 $9.93 Million
Q4 2021

Feb 11, 2022

BUY
$16.14 - $25.04 $549,276 - $852,161
34,032 Added 10.6%
355,140 $5.8 Million
Q3 2021

Nov 12, 2021

BUY
$17.52 - $27.93 $5.63 Million - $8.97 Million
321,108 New
321,108 $6.87 Million

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $660M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.